PPARGC1A and acute myeloid leukemia: A study by Li-Cheng et al. demonstrated that both gene and protein expression levels of SIRT1 and peroxisome proliferator–activated receptor gamma coactivator (PGC)-1 alpha were higher in AML cells resistant to cytosine arabinoside (AraC) than in primary AML samples [53].